U.S. Peptide Therapeutics (Retail Side) Market Size, Share & Trends Analysis Report By Peptide Type, By Indication, By Route of Administration, By Therapeutics Type, By Distribution Channel, And Segment Forecasts, 2025 - 2033
TruePill(acquired by LetsGetChecked in October 2024)
AgelessRx
Specialized Hormone Clinics
Defy Medical
Renew Vitality
Victory Men's Health
Hone Health
Joi & Blokes
Ways2Well
KSM
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
U.S. Peptide Therapeutics (Retail Side) Market Summary
The U.S. peptide therapeutics (retail side) market size was estimated at USD 103.66 billion in 2024 and is expected to reach USD 336.12 billion by 2033, growing at a CAGR of 12.77% from 2025 to 2033. The increasing number of pediatric patients affected by these conditions, coupled with their widespread occurrence in low-income regions, highlights the need for affordable and effective treatment options. In addition, the increasing number of pediatric patients affected by these conditions, coupled with their widespread occurrence in low-income regions, underscores the need for affordable and effective treatment options.
U.S. Peptide Therapeutics (Retail Side) Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033 For this study, Grand View Research has segmented the U.S. peptide therapeutics (retail side) market report based on peptide type, therapeutics type, indication, route of administration, and distribution channel:
Peptide Type Outlook (Revenue, USD Billion, 2021 - 2033)
GLP-1 Peptides
Wellness/Longevity/Healthspan Peptides
Peptides for Other Acute or Chronic Medical Conditions
Therapeutics Type Outlook (Revenue, USD Billion, 2021 - 2033)
Innovative (Branded) Peptides
Biosimilar Peptides
Generic Peptides
Indication Outlook (Revenue, USD Billion, 2021 - 2033)
Type 2 Diabetes
Obesity / Weight Management
Neuroendocrine Tumors
Acromegaly
Growth Hormone Deficiency
Prostate Cancer
Osteoporosis
Breast Cancer (hormone-sensitive)
Endometriosis
Others
Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
Parenteral
Oral
Transdermal
Nasal
Others
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
Offline Retail Pharmacies
Chain pharmacies
Specialty retail pharmacies
Independent community pharmacies
Online Pharmacies / Telehealth
Others (Specialized Peptide Clinics
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR's Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Peptide Therapeutics (Retail Side) Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Therapeutics type & indication segment outlook
2.1.2.2. Route of administration & distribution channel segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter's Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.6. Pricing Analysis in Online vs. Offline Channels
3.7. Consumer Awareness Trends for Peptide Therapies
3.8. Direct-to-Consumer (DTC) Business Models Impact
Chapter 4. Peptide Type Business Analysis
4.1. U.S. Peptide Therapeutics (Retail Side) Market: Peptide Type Movement Analysis
4.2. U.S. Peptide Therapeutics (Retail Side) Market: Peptide Type Segment Dashboard
4.3. Peptide Type Movement & Market Share Analysis, 2024 & 2033
4.4. U.S. Peptide Therapeutics (Retail Side) Market Estimates & Forecast, by Peptide Type